39
Views
20
CrossRef citations to date
0
Altmetric
Review

PDE4 inhibitors 1998

Pages 771-784 | Published online: 25 Feb 2005
 

Abstract

The search for novel phosphodiesterase Type 4 (PDE4) inhibitors is currently one of the most active fields within the pharmaceutical industry. Recent progress in the clinical development of PDE4 inhibitors is reviewed. Particular emphasis is placed on those patents published within the past two years, highlighting the novel structural classes of PDE4 inhibitors reported.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.